Dermavant Centralizes and Transforms its SCE Overnight with No Delay to its Drug Development Program

Taking Clinical Trial Analytics to the Next Level with Accel™ Cloud-Based SCE

Dermavant Sciences is a growing mid-market specialty biopharma company developing innovative medicines for dermatologic diseases.

Learn how they upgraded their biostatistics workflow with a turnkey, cloud hosted, and validated statistical computing environment (SCE), with no disruption to their drug development program.

Thanks to Instem, the Dermavant Sciences now had:

• The ability to continue to execute their current processes with little to no impact on the end users
• A centralized and compliant system to minimize the compliance risk of delivering their clinical trial results
• Their system implementation and ongoing maintenance burden removed from Dermavant’s 
  internal IT department enabling them to focus on more strategic technology initiatives